Clinical Trial: Behavior Enhances Drug Reduction of Incontinence (BE-DRI)


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) National Institute of Child Health and Human Development (NICHD)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

The primary aim of this study is to test if the addition of behavioral treatment to drug therapy for the treatment of urge incontinence will increase the number of patients who can discontinue drug therapy and sustain a significant reduction of incontinence.

Condition	Treatment or Intervention	Phase
Urinary Incontinence	Drug: Tolterodine Behavior: Combination Drug (tolterodine) and Behavior Treatment	Phase II Phase III

Ages Eligible for Study: 21 Years and above, Genders Eligible for Study: Female

Accepts Healthy Volunteers

Criteria

Sharon L Tennstedt, Ph.D. (617) 923-7747 Ext. 362 sharont@neri.org
Kimberly Dandreo, M.S. (617) 923-7747 Ext. 219 kdandreo@neri.org

Alabama
University of Alabama, Birmingham, Alabama, 35233, United States; Recruiting

Holly Richter, MD 205-934-7874 hrichter@uabmc.edu
Alice A Howell, RN 205-975-8592 ahowell@uabmc.edu
Holly Richter, MD, Principal Investigator
L. Keith Lloyd, MD, Sub-Investigator
Rowell Ashford, MD, Sub-Investigator
Kathryn Burgio, PhD, Sub-Investigator
Seine Chiang, MD, Sub-Investigator
Patricia S. Goode, MD, Sub-Investigator
Lee Hammontree, MD, Sub-Investigator
R. Edward Varner, MD, Sub-Investigator

California
University of California, San Diego, California, 92103, United States; Recruiting

Michael Albo, MD 858-657-8435 malbo@ucsd.edu
D. Lynn Kalinoski, PhD 619-543-2169 dkalinos@ucsd.edu
Michael Albo, MD, Principal Investigator
Charles Nager, MD, Sub-Investigator
Christine Dorr, MD, Sub-Investigator
Karl M. Luber, MD, Sub-Investigator
Emily Lukacz, MD, Sub-Investigator
Amanda Simsiman, MD, Sub-Investigator

Illinois
Loyola University Medical Center, Maywood, Illinois, 60153, United States; Recruiting

Linda Brubaker, MD 708-216-2170 lbrubaker@lumc.edu
Kathy Jesse, RN 708-216-8944 kjesse1@lumc.edu
Linda Brubaker, M.D, Principal Investigator
MaryPat Fitzgerald, MD, Sub-Investigator
Kimberly Kenton, MD, Sub-Investigator

Maryland
University of Maryland, Baltimore, Maryland, 21201, United States; Recruiting

Toby Chai, MD 410-328-5544 tchai@smail.umaryland.edu
Judith Murray, CCRC 410-328-5784 jmurray@smail.umaryland.edu
Toby Chai, MD, Principal Investigator
Harry Johnson, MD, Sub-Investigator

Michigan
Oakwood Hospital and Medical Center, Royal Oak, Michigan, 48123, United States; Recruiting

Veronica Mallett, MD 313-436-2201 mallettv@oakwood.org
Kathryn Koches, RN 313-436-2242 kochesk@oakwood.org
Ananias C Diokno, MD, Principal Investigator
Veronica Mallett, MD, Sub-Investigator
Salil Khandwala, MD, Sub-Investigator

Pennsylvania
University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States; Recruiting

Halina Zyczynski, MD 412-641-1440 hzyczynski@mail.magee.edu
Judith Gruss, RN 412-641-5388 jgruss@mail.magee.edu
Halina Zyczynski, MD, Principal Investigator
Wendy Leng, MD, Sub-Investigator
Pamela A Moalli, MD, Sub-Investigator
Elizabeth Sagan, MD, Sub-Investigator

Texas
University of Texas Southwestern, Dallas, Texas, 75390, United States; Recruiting

Philippe Zimmern, MD 214-648-9397 philippe.zimmern@utsouthwestern.edu
Norma Pope, RN, WHNP 214-645-8791 norma.pope@utsouthwestern.edu
Philippe Zimmern, MD, Principal Investigator
Gary E. Lemack, MD, Sub-Investigator
Muriel Boreham, MD, Sub-Investigator
Mikio Nihira, MD, MPH, Sub-Investigator
Joseph Schaffer, MD, Sub-Investigator
Clifford Wai, MD, Sub-Investigator

University of Texas Health Sciences Center, San Antonio, Texas, 78229, United States; Recruiting

Stephen Kraus, MD 210-567-5650 krauss@uthscsa.edu
Sylvia Escobedo Sluder, CCRP 210-567-0550 sluder@uthscsa.edu
Stephen Kraus, MD, Principal Investigator
Ash Dabbous, MD, Sub-Investigator
Alayne Markland, DO, Sub-Investigator

Utah
University of Utah, Salt Lake City, Utah, 84132, United States; Recruiting

Peggy Norton, MD 801-581-3565 peggy.norton@hsc.utah.edu
Shelly O'Meara, RN 801-581-6874 shelly.omeara@hsc.utah.edu
Peggy Norton, MD, Principal Investigator
Lindsey Kerr, MD, Sub-Investigator
Jan Baker, APRN, Sub-Investigator
David Lesser, MD, Sub-Investigator

Study chairs or principal investigators

Study ID Numbers: BE-DRI
Record last reviewed: August 2004
Record first received: August 27, 2004
ClinicalTrials.gov Identifier: NCT00090584
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08